---
title: "301207.SZ (301207.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301207.SZ/news.md"
symbol: "301207.SZ"
name: "301207.SZ"
parent: "https://longbridge.com/en/quote/301207.SZ.md"
datetime: "2026-03-10T00:29:47.286Z"
locales:
  - [en](https://longbridge.com/en/quote/301207.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301207.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301207.SZ/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/301207.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/301207.SZ/news.md)


# 301207.SZ (301207.SZ) — Related News

### [High-end vaccine Li Sixian: This year is a year of rapid development, striving for the enterovirus 71 vaccine in the ASEAN market](https://longbridge.com/en/news/277700715.md)
*2026-03-04T00:56:18.000Z*
> The general manager of High-end Vaccines, Li Sixian, stated that 2026 will be a year of rapid growth for the company, pl

### [High-end vaccines have submitted an application to the Singapore Health Sciences Authority to seek approval for the market launch of the enterovirus 71 vaccine in Singapore](https://longbridge.com/en/news/277341281.md)
*2026-03-01T06:51:01.000Z*
> High-end Vaccines (6547) has submitted a new drug review application for the EV71 vaccine to the Health Sciences Authori

### [](https://longbridge.com/en/news/273937989.md)
*2026-01-28T05:31:20.000Z*
> A-share pharmaceutical and medical stocks experienced volatile adjustments, with BeBetter Med falling nearly 15%. ACROBI

### [Intraday News - High-end Vaccine (6547) Plummets -3.88% to 43.35 Yuan, with a trading volume of 7,145 shares](https://longbridge.com/en/news/273913338.md)
*2026-01-28T01:13:36.000Z*
> High-end Vaccines (6547-TW) stock price plummeted 3.88%, closing at NT$ 43.35, with a trading volume of 7,145 shares. To

### [](https://longbridge.com/en/news/273827826.md)
*2026-01-27T10:29:55.000Z*
> Hualan Vac: The industry in which the company operates is the human vaccine manufacturing industry, with the main produc

### [The Nipah virus outbreak catalyzes! VIGONVITA-B surges 11% to reach a new high, is VV116 the key trump card?](https://longbridge.com/en/news/273782005.md)
*2026-01-27T03:20:25.000Z*
> The Nipah virus outbreak in West Bengal, India, has led to multiple infections, affecting the performance of vaccine sto

### [Pandemic prevention stocks become today's dark horse! India establishes a hundred viruses, with Evergrande, Maobao, High-end Vaccine, and eight other stocks lighting up](https://longbridge.com/en/news/273776390.md)
*2026-01-27T02:32:59.000Z*
> Recently, India has experienced an outbreak of the Lipa virus, and the Ministry of Health and Welfare has classified it 

### [Five cases of Nipah virus confirmed in India, multiple A-share vaccine stocks hit the daily limit](https://longbridge.com/en/news/273703029.md)
*2026-01-26T12:48:49.000Z*
> Five cases of Nipah virus infection have been confirmed in West Bengal, eastern India, leading to a significant market r

### [A-share closing review: The Shanghai Composite Index fluctuated within a narrow range throughout the day, while the Shenzhen Component Index and the ChiNext Index opened high and closed low](https://longbridge.com/en/news/273659924.md)
*2026-01-26T07:04:08.000Z*
> The three major A-share indices opened higher in the morning but then fluctuated lower, with the Shenzhen Component Inde

### [Nipah virus outbreak in India! Vaccine stocks collectively rise, CanSinoBIO up over 12%, Wantai Biological up nearly 6%](https://longbridge.com/en/news/273658831.md)
*2026-01-26T06:58:49.000Z*
> On January 26th, the A-share market saw a collective surge in vaccine stocks, with Hualan Vac and GDK Biotech hitting th